Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection by Paolo, Mosci et al.
Microbes and Infection 16 (2014) 678e689
www.elsevier.com/locate/micinfOriginal article
Involvement of IL-17A in preventing the development of deep-seated
candidiasis from oropharyngeal infection
Paolo Mosci a,1, Elena Gabrielli b,1, Eugenio Luciano b, Stefano Perito b, Antonio Cassone b,
Eva Pericolini b, Anna Vecchiarelli b,*
a Internal Medicine Section, Department of Veterinary Medicine, University of Perugia, Perugia, Italy
b Microbiology Section, Department of Experimental Medicine, University of Perugia, Perugia, Italy
Received 22 January 2014; accepted 16 June 2014
Available online 27 June 2014AbstractIn this study we show that corticosteroid-treated Il17a/ mice develop invasive candidiasis from oropharyngeal infection whereas WT mice
do not. By using an established murine model of oral candidiasis we document the spatial and temporal progression of fungal infection. The
histological analysis of tissues in Il17a/ mice showed massive infiltration of the fungus in the stomach and alterations of the gastrointestinal
tract segments. Both increased permeability and mucosal ulcerations of the intestinal barrier are seen to favor Candida albicans dissemination
which was quantified both in kidney and liver where typical candidal abscesses were detected. Neutrophils from Il17a/ were as capable of
phagocytosing the fungus comparable to that of WT mice, however, they showed decreased candidacidal ability. Our data implies that IL-17A is
crucial for preventing the passage from mucosal to disseminated candidiasis. As such, our model may be suitable to study the mechanisms
favoring C. albicans translocation to internal organs.
© 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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Candida albicans (C. albicans), one of the most relevant
fungal pathogens, causes different types of superficial in-
fections including oral and vaginal candidiasis, and can
disseminate systemically leading to high rate of morbidity and
mortality [1]. Compelling evidence shows that the oral cavity
can be the site of origin for dissemination of pathogenic mi-
croorganisms to distant body sites, particularly in immuno-
compromised hosts, and C. albicans makes no exception [2,3].
Interleukin (IL)-17A is considered a key cytokine for host
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recent study, allelic variations of genes of the IL-17 pathway
have been associated to chronic mucocutaneous candidiasis
[7]. It is well established that Th17 as well as IL-17RA re-
ceptor are critical in the defense against oropharyngeal
candidiasis (OPC), in particular research by Gaffen's group
unequivocally demonstrated that Th17 cells secreting IL-17A
play a key role in OPC, while Th1 cells and IL-22 seem to
play a minor role [8].
More recently, the same research group reported that
Th17 cells are also important in conferring long-term adaptive
immunity to OPC [9]. Despite all this important information
above, the mechanism that leads to impairment of antifungal
immunity in animals lacking functional Th17 cells or unable
to secrete IL-17A is not fully clarified. Several hypothesis
have been advanced including the inhibition of neutrophils
recruitment and lack of gene expression of chemokines and
GM-CSF [10,11]. Despite the importance of IL-17A in thereserved.
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exists about the role of IL-17A in preventing systemic
candidiasis from mucosal infection.
In the present study, based on real-time in vivo imaging
technique, we used a recently established model of OPC [12]
to evaluate the role of IL-17A in preventing the translocation
of C. albicans from local to systemic compartment.
2. Materials and methods2.1. C. albicans strain and cultureC. albicans CA1398 carrying the ACT1p-gLUC59 fusion
(gLUC59) was used [13]. The gLUC59 luciferase reporter has
previously been described [13]. C. albicans gLUC59 was
cultured in YPD (yeast peptone dextrose) as described by Solis
et al. [14].2.2. Ethics statementAll animal experiments were performed in agreement with
the EU Directive 2010/63, the European Convention for the
Protection of Vertebrate Animals used for Experimental and
other Scientific Purposes, and the National Law 116/92. The
protocol was approved by Perugia University Ethics Com-
mittee for animal care and use (Comitato Universitario di
Bioetica, permit number 149/2009-B). All the animals were
housed in the animal facility of the University of Perugia
(Authorization number 34/2003A).2.3. Mouse model of OPCFemale, 6e8 weeks old, inbred C57BL/6J mice (WT)
(Harlan Nossan Laboratories, Milan, Italy) and C57BL/6J
knock out for IL-17A isoform, homozygote (Il17a/) mice
[15,16] (Center for Experimental Medicine and Systems
Biology, University of Tokio, Minato-ku, Tokio, Japan) were
housed at the Animal Facilities of the University of Perugia.
Mice were treated with 225 mg/kg cortisone acetate (Sigma-
eAldrich) and infected with 1  106/ml C. albicans suspen-
sion as previously described [14] under anesthesia with a
subcutaneous (s.c.) injection of a mixture of Tiletamine/
Zolazepam-Xylazine (50 mg/kg-5 mg/kg) [12]. The same
infection was also performed in corticosteroid-untreated mice.
The oral cavity was swabbed immediately before the infection
and streaked on YPD agar plus chloramphenicol (50 mg/ml)
(both from SigmaeAldrich) to verify the absence of Candida
spp. In selected experiments gut samples obtained before and
after infection have been plated onto CHROMagar™ Candida
medium (CHROMagar, Paris, France), a cromogenich medium
which selects colonies of different Candida species based on
the colony color. The Il17a/ status of the mice was
confirmed by using a specific ELISA kit detecting the pres-
ence of IL-17A/F heterodimers (eBioscience, Inc.). Moreover,
the IL-17B levels by specific ELISA kit was also evaluated
(eBioscience, Inc.). No IL-17A/F heterodimers were observed
in serum samples of Il17a/ mice pre and post-infectionwhile IL-17B isoform was produced to similar level in both
WT and Il17a/ mice.2.4. Real-time monitoring of OPCAt selected days, starting on day 1 after challenge, 10 ml
(0.5 mg/ml in 1:10 methanol:H2O) of coelenterazine (Syn-
chem, OHM) was added sublingually. Mice were then imaged
in the IVIS-200TM Imaging system (Xenogen Inc.) under s.c.
anesthesia and then the total photon emission from oral areas
within the images (Region Of Interest, ROI) was quantified as
previously described [12]. No background luminescence was
observed in uninfected mice treated with coelenterazine (data
not shown). In selected experiments an ex vivo analysis of
pharynx, esophagus and stomach from mice with OPC was
performed after 3, 6 and 8 days post-infection as previously
described [12]. After 8 days post-infection an ex vivo analysis
of liver and kidneys of mice with OPC was performed. Briefly,
liver and kidneys were excised from euthanized mice, the
latter were dissected and then both soaked with 10 ml (0.5 mg/
ml) of coelenterazine (Synchem) to visualize the fungal
burden as above described.2.5. CFU assayThe fungal burden of the tongue, esophagus, stomach, liver,
duodenum, ileum and kidneys 3, 6 and 8 days post-infection
was evaluated as previously described [12]. In selected ex-
periments gut samples have been also plated onto CHRO-
Magar™ Candida medium (CHROMagar, Paris, France).
Moreover, to analyze whether C. albicans was present in the
peritoneal cavity of WTor Il17a/ mice, the peritoneal cavity
from both mice was washed with 5 ml RPMI-1640 8 days
post-infection. The washes were centrifuged, resuspended with
1 ml of RPMI-1640 and then plated onto CHROMagar™
Candida medium (CHROMagar). No Candida species were
recovered. The disease severity was also evaluated by moni-
toring individual mice for weight loss.2.6. Candidacidal assaysAfter 6 days of OPC infection, peritoneal murine neutro-
phils from WT or Il17a/ mice were collected 18 h after the
intraperitoneal injection of 0.5 ml endotoxin-free 10% thio-
glycolate solution (Difco). Neutrophils (4  106/ml) were
incubated in the presence or absence of recombinant mouse
IL-17A (rIL-17A) (100 ng/ml, eBioscience) for 30 min at
37 C plus 5% CO2 in RPMI-1640, then washed twice and
resuspended in RPMI-1640. The oxidative burst of neutro-
phils was carried out by labeling cells (4  106/ml) with
1 mM of 2',7'-dichlorofluoresceindiacetate (DCFH-DA) for
30 min at room temperature. Cells were then incubated with
PMA (SigmaeAldrich) (100 ng/ml) or C. albicans
gLUC59 cells (2  106/ml) into a black 96 wells plates
(Nunc) and then the emission of fluorescence was measured in
the Tecan plate reader at 25 kinetic cycles and interval time of
5 min.
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was determined by CFU inhibition assay. Briefly, neutrophils
(105 cells) in 0.1 ml suspension/well were incubated in flat-
bottom 96-well microtitre tissue culture plates with 104 cells
C. albicans gLUC59 in 0.1 ml RPMI plus 5% FCS and
incubated for 2 h at 37 C plus 5% CO2. After incubation,
plates were vigorously shaken and cells were lysed by adding
Triton X-100 (0.1% in distilled water; final concentration in
the well 0.01%). Serial dilutions were prepared in distilled
water from each well. The samples were then spread on
Sabouraud dextrose agar plus chloramphenicol (50 mg/ml) in
triplicate and CFU values were evaluated after 24 h of incu-
bation at 37 C. Control coltures consisted of C. albicans
gLUC59 incubated in RPMI-1640 plus 5% FCS without
effector cells. In selected experiments, 90 ml of freshly
collected murine saliva, recovered after injection of 0.2 ml
pilocarpine (0.5 mg/kg, s.c. injection) [17], from uninfected or
infected mice (day þ6), was incubated with 104 cells of C.
albicans gLUC59 for 1 h at 37 C, plated in triplicate and
assayed for colony enumeration [8]. Killing activity was
expressed as the percentage of CFU inhibition according to the
following formula: % killing activity ¼ 100  (CFU experi-
mental/CFU control)  100.
To test the phagocytic capacity of cells, neutrophils
(1  105/200 ml), after stimulation with C. albicans gLUC59
(2  105/200 ml), were collected by cytospin (700 g for 7 min)
and stained by Hemacolor. The fungal cell internalization was
expressed according to the following formula: percentage of
internalization ¼ number of cells containing one or more
fungal cells/100 cells counted.
To provide information about the proportion of neutrophils
in the cellular preparation from the peritoneal cavity of
thioglycollate-injected WT and Il17a/ infected mice, cells
were fixed with 1.5% formalin, washed, reacted with FITC-
conjugated monoclonal antibody (mAb) to Ly-6G (Gr-1)
(0.05 mg/test, Rat IgG2b, kappa, eBioscience, Inc.) for 20 min at
room temperature in the dark. After incubation, cells were
washed twice with 1X PBS plus 1% FCS and 0.5% NaN3 2M
(fluorescence buffer (FB)), resuspended in 0.5 ml of FB and
then analyzed by flow cytometry using FACSCalibur (Becton
Dickinson). Data are expressed as percentage of Gr-1 positive
cells. Autofluorescence was assessed using untreated cells.
Control staining of cells with irrelevant antibody was used to
obtain background fluorescence values.2.7. Histological analysisEight days post-infection the animals were sacrificed to
analyze gross and histopathologic lesions and tongue, esoph-
agus, stomach, small intestine, liver and kidney tissues were
excised. The macroscopic lesions were digitally photographed
(Sony Mavica MVC-CD400). Then the tissues were fixed
immediately in 10% formalin, then embedded in paraffin. The
tongues and stomachs were sectioned longitudinally to verify
the extension of the lesions, the esophagus, small intestine,
liver and kidneys were sectioned transversally. The 3e5 mm
thick sections were stained using the periodic acid-Schiff(PAS) procedure to visualize fungi, and examined by light
microscopy (Leica DM2500). The scale bars are in mm.2.8. Statistical analysisThe data are reported as the mean ± s.e.m. from triplicate
samples of three-five experiments. The photon flux emission
was compared using Student's t test. CFU counts, weight loss,
phagocytic and killing activities of neutrophils were compared
using ManneWhitney U test. A value of p < 0.05 was
considered significant.
3. Results3.1. Real-time monitoring of OPC in Il17a/ miceFirstly, we determined the course of OPC in corticosteroid-
treated Il17a/ mice compared with corticosteroid-treated
but Il17a competent counterpart (WT). To this end, mice were
treated subcutaneously with cortisone acetate every two days
starting 1 day before infection. We exploited a new in vivo im-
aging technique that we recently validated [12]. This allows
real-time monitoring of the spatial and temporal progression of
infection. Briefly, the mice were sublingually infected with
blastospores of C. albicans and the course of candidiasis was
monitored 1, 3, 6 and 8 days after challenge. In Fig. 1 are re-
ported the results of the real-time monitoring of infection. The
Il17a/ mice showed a marked increase of susceptibility to
infection as compared to the WT animals, as visually evident
(Fig. 1A), and as measured by total photon emission (Fig. 1B).
Significant increase of luminescence signals, obtained
following administration of the luciferase substrate coelenter-
azine in the oral cavity in Il17a/mice, was already observed 3
days after challenge. A dramatic increase was manifested in
subsequent days (dayþ6 and dayþ8). TheWTmice developed
an appreciable degree of infection only on day þ6 to day þ8
(Fig. 1). At day þ8, all animals were humanely sacrificed.
Macroscopic analysis of tongue and esophagus showed C.
albicans marked alteration in Il17a/ mice with respect to
WT at day þ8 post-infection (Fig. 2A).
Fungal load was also assessed by ex vivo bioluminescence
emission of explanted esophagus and stomach. No apparent
bioluminescence was manifested 3 days after infection in
Il17a/ and WT mice counterpart. However, clear and
intense signals from both organs of Il17a/ mice were
detected after 6 days, and a very strong signal was manifested
when the monitoring was performed after 8 days, in keeping
with in vivo data (Fig. 2B).
The fungal load in various organs was also monitored by
CFU counts in tongue, esophagus, stomach, liver, duodenum,
ileum and kidneys. The results reported in Fig. 3A show that
the fungal load was significantly increased in tongue, esoph-
agus and stomach of Il17a/ mice as compared to WT mice.
This difference was detected 6 days post-infection and reached
a maximum 8 days after challenge. As previously observed
[12], in WT mice an increase of fungal load was observed 8
days post-infection [12]. Surprisingly, in the duodenum and
Fig. 1. In vivo imaging of OPC. Il17a/ and WT mice were infected with C. albicans gLUC59 (1  106/ml). 1, 3, 6 and 8 days post-infection anesthetized mice
were treated sublingually with 10 ml of coelenterazine (0.5 mg/ml) and imaged in the IVIS-200TM Imaging system. Data are from one of three experiments with
similar results. Total photon flux from oral areas in the images (ROI) of each mouse was quantified with Living ImageR software package (A). The statistical
significance of Total photon flux from ROI was evaluated with the Student's t test. A value of p < 0.05 was considered significant (day þ3, þ6 and þ8 post
challenge vs day þ1; day þ6 post challenge vs day þ3) (B).
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similar in WT and Il17a/ mice (Fig. 3D). It has been
recently reported that the mouse gut contains plenty of fungi,
with another Candida species [18]. In our experimental sys-
tem, species of Candida other than albicans were not detected
(data not shown). When the CFU was monitored in the liver
(Fig. 3B, left panel) and in the kidneys (Fig. 3C, left panel)
significant differences were observed. In particular, a pro-
gressive increase of Candida load was detected in both organs
of Il17a/ mice while no fungus presence was detected in
WT mice. The presence of fungal cells in liver and kidneys
exclusively in Il17a/ mice was also verified by biolumi-
nescence in an ex vivo analysis (Figs. 3B and C, right panels).
Fungal invasion of internal organs in Il17a/ mice was
associated with a rapid weight loss starting 6 days after
challenge (Fig. 3E). Notably, the WT mice did not show such
rather relevant clinical sign, and only at late time (day þ8)
there was a significant weight loss, though much smaller than
the weight loss of Il17a/ mice (Fig. 3E). In our experimental
system Il17a/ mice without steroid treatment did not
develop systemic candidiasis from local infection (unpub-
lished data).3.2. Histological analysisIn order to characterize the lesions associated with the
OPC, we performed a histological analysis of tongue,esophagus, stomach, small intestine, liver and kidney on day 8
post-infection (Figs. 4 and 5).
The longitudinal sections of the tongue of Il17a/ mice
showed a massive fungal colonization of whole dorsal layer of
the organ with the formation of pseudomembranous plaques.
Cluster of fungi and few inflammatory cells were also present
in the epithelium of ventral surface of the tongue. The dorsal
papillary architecture appeared to be totally destroyed with
loss of the keratinized superficial epithelium (Fig. 4A). Large
and extensive erosions, at places terminating in ulcerations,
were also evident in the central region of the tongue, in as-
sociation with massive infiltration of inflammatory cells and
presence of some invasive fungal hyphae and blastospores,
eventually also penetrating the muscular tissue of the organ.
Differently from Il17a/ mice, the fungal invasion of the
tongue of WT mice was much less severe and limited to a
portion of the surface with formation of similar pseudomem-
branes. The mucosa surrounding the fungal burden was intact
in all of WT mice. The fungi and inflammatory cells appeared
to be confined to the keratinized layer of the tongue with
microabscesses formation (Fig. 4A).
In the esophageal sections of the Il17a/ mice the lumen
of the organ appeared enlarged and completely obstructed by
massive burdens of fungal, inflammatory neutrophils and
desquamated epithelial cells. The mucosa showed pseudo-
membranes, diffuse fungal and inflammatory cells invasion,
severe erosion with ulcers deranging the spinous layer, with
Fig. 2. Analysis of target organs. Microscopic analysis of tongue and esophagus recovered after 8 days of infection from Il17a/ and WT mice with OPC was
shown (A). Ex vivo analysis of infected pharynx, esophagus and stomach from Il17a/ and WT mice with OPC was shown. 3, 6 and 8 days post-infection, mice
were euthanized, gastric tracts were excised and 10 ml of coelenterazine (0.5 mg/ml) were injected through the pharynx into esophagus lumen to visualize the
fungal burden and localization by the IVIS-200TM Imaging system. Data are from one of three experiments with similar results. ROI was quantified with Living
ImageR software package (B).
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seen to surround the invading fungal cells so as to suggest the
formation of an inflammatory barrier (Fig. 4B).
In the esophagus of WT mice the few fungal burden and the
inflammatory cells appeared confined to a superficial layer of
the mucosa without involvement of the spinous layer. The
organ doesn't appear enlarged and results moderated obstruc-
ted by few hyphae and inflammatory cells (Fig. 4B).
In the stomach section of Il17a/ mice a severe diffuse
hyperplasia and hyperkeratosis of the whole forestomach were
observed. Moreover, the fungal cells were localized in the
forestomach, cardium atrial fold (CAF) and adjacent glandular
mucosal surface and in this area an extensive erosion was
evident. Hyphae and inflammatory cells, neutrophils and
mononucleated cells, penetrated beyond the epithelium deeply
within lamina propria. On the contrary, in the forestomach,
fungal cells remain localized to the keratinized layer accom-
panied by a mononuclear cell infiltrate and the reaction doesn't
involve the underlying spinous layer (Fig. 4C).
In the stomach of theWTmice a similar hyperplastic reaction
was observed while fungal burden or inflammatory reaction
were not detected either in the non glandular area or in the
glandular one. Mucosal erosion, fungal and inflammatory
infiltratewere evident in the portion of stomach cardia (Fig. 4C).
Histological section of the small intestine of Il17a/ mice
showed a severe mucosal damage with the loss of the entire
intestinal epithelium, vascular congestion and edema, and theintestinal villi appeared almost completely destroyed. No
gross damage was observed in WT mice which had totally
preserved intestinal villi (Fig. 5A). Finally only in Il17a/
mice an involvement of liver and kidneys was observed. In
particular, abscesses characterized by a necrotic central area
surrounded by a mass of fungal elements containing both
blastospores and hyphae, and an infiltration of neutrophils and
mononucleated cells were detected in the liver and kidneys of
Il17a/ mice. The colonization of liver and kidneys in these
mice evidences the disseminated infection (Fig. 3B and C and
Fig. 5B and C). No lesions or/and fungi were found in the liver
and kidneys of WT mice (Fig. 5B and C).3.3. Candidacidal assaysThere is rather compelling evidence that neutrophils play a
fundamental role in the defense against invasive candidiasis
[19]. Since the histological observations reported above
showed the presence of neutrophils-containing inflammatory
infiltrates at the various sites of the gastrointestinal tract in
Il17a/ mice, we wondered about the functional capacity of
neutrophils from Il17a/ mice. Thus, we assayed the peri-
toneal neutrophils candidacidal activity of uninfected and
infected mice (day 0 and day þ6 after challenge). The per-
centage of Gr-1 positive cells evaluated in the cellular prep-
aration obtained from both infected groups after thioglycolate
treatment was comparable (90% in both groups).
Fig. 3. Fungal burden in target organs and effect of infection in body weight. Fungal burden of WT and Il17a/ mice with OPC was evaluated 3, 6 and 8 days
post-infection in tongue, esophagus and stomach (A), in liver (B, left panel), kidney (C, left panel), duodenum and ileum (D) *p < 0.05 (Il17a/ vs WT mice)
according to ManneWhitney U test. Ex vivo analysis of infected liver and kidneys from Il17a/ and WT mice with OPC was shown. After 8 days post-infection
mice were euthanized, liver and kidneys were excised, dissected and then soaked with 10 ml of coelenterazine (0.5 mg/ml) to visualize the fungal burden using the
IVIS-200TM Imaging system. Data are from one of three experiments with similar results. ROI was quantified with Living ImageR software package (B and C,
right panels). Time course of weight change (%) in cortisone acetate treated WT and Il17a/ mice with OPC was shown (E). *p < 0.05 (day þ6 and day þ8 post
challenge vs day 1) according to ManneWhitney U test.
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mice expressed similar levels of phagocytic activity as
compared to that from WT mice (day 0 and day þ6); however,
after 6 days the phagocytic activity was increased as compared
to day 0. Although both mice showed similar levels of killing
activity at day 0, Il17a/mice displayed a drastic reduction of
killing activity at dayþ6 post-infection unlike theWT in whichthe killing activity was increased. However, at this time point
Il17a/ mice displayed a lower intrinsic oxidative burst
(Fig. 6A, left panels), whichever the stimulant. Preincubation of
neutrophils from Il17a/ mice with murine rIL-17A did not
rescue the reduced antifungal capacity of these neutrophils. No
modulation of antifungal activity was also observed in neutro-
phils from WT mice (Fig. 6A, right panels and Fig. 6C).
Fig. 4. Histopathology of tongue, esophagus and stomach. The tissue sections from Il17a/ and WT infected mice were shown (day þ8 post-infection). Tongue
sections (A, right panels, scale bar 1.0 mm and enlargement view 100 mm) of Il17a/ infected mice showed fungal and inflammatory cells infiltration penetrating
into submucosa up to muscular layers, even throughout the entire tongue (arrow). In the tongue sections (A, left panels, scale bar 1.0 mm and enlargement view
100 mm) of WT infected mice the fungal invasion was much less severe. The fungi and inflammatory cells appeared to be confined to the keratinized layer of the
tongue (arrow). In the esophageal sections (B, right panels, scale bar 500 mm and enlargement view 200 mm) of Il17a/ infected mice severe erosions were evident
with massive infiltrations of inflammatory cells (arrow). In the esophageal sections (B, left panels, scale bar 500 mm and enlargement view 100 mm) of WT infected
mice the fungal burden and the inflammatory cells appeared confined to a superficial layer of the mucosa without involvement of the spinous layer (arrow). In the
stomach sections (C, right panels, scale bar 1.0 mm and enlargement view 50 mm) of Il17a/ infected mice a severe diffuse hyperplasia and hyperkeratosis of the
whole forestomach were observed (head arrow). Hyphae and inflammatory cells, neutrophils and mononucleated cells, penetrated beyond the epithelium deeply
within lamina propria (asterisk). In the forestomach, fungal cells remain localized to the keratinized layer (arrow). In the stomach sections (C, left panels, scale bar
1.0 mm and enlargement view 100 mm) of WT infected mice a similar hyperplastic reaction was observed (head arrow).
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the site of infection, the killing activity of saliva was analyzed.
Saliva was collected, after pilocarpine injection, from WT and
Il17a/ mice and incubated with C. albicans cells. No sta-
tistical differences of the candidacidal activity of saliva taken
from WT and Il17a/ mice before challenge were observed
(Fig. 6B). A statistically significant increase of candidacidal
activity of saliva from WT mice was observed 6 days post-
infection compared to the pre-infection level, while thekilling activity of saliva from Il17a/ mice resulted
completely abolished post-infection (Fig. 6B).
4. Discussion
C. albicans is part of normal microflora of the mucosa and
particularly of the reproductive and gastrointestinal tracts [20].
Asymptomatic carriage of oral yeast has been seen to be present
in about 60% of normal [21] to reach greater than 80% in HIV-
Fig. 5. Histopathology of small intestine, liver and kidneys. The small intestine sections (A, right panels, scale bar 500 mm and enlargement view 200 mm) of
Il17a/ infected mice showed a severe mucosal damage with the loss of the entire intestinal epithelium, vascular congestion and edema, and the intestinal villi
appeared almost completely destroyed (arrow). No such damages were observed in small intestine sections (A, left panels, scale bar 500 mm and enlargement view
200 mm) of WT infected mice. The liver sections (B, right panels, scale bar 500 mm and enlargement view 100 mm) of Il17a/ infected mice showed abscesses
characterized by a necrotic central area surrounded by a mass of fungal elements containing both blastospores and hyphae, and an infiltration of neutrophils and
mononucleated cells (arrow). No lesions in the liver of WT infected mice were observed (B, left panels, scale bar 1.0 mm and enlargement view 100 mm). The
kidneys sections (C, right panels, scale bar 1.0 mm and enlargement view 100 mm) of Il17a/ infected mice showed abscesses and extensive inflammatory
reaction that are diffuse in the cortex and medullary area. Large aggregates of yeasts and dense leukocytic infiltration surrounding a necrotic area of cortical zone
(arrow). No evidence of inflammatory reaction of fungal cells were observed in the kidneys of WT infected mice (C, left panels, scale bar 1.0 mm and enlargement
view 100 mm).
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the most common infection, that can spread to esophagus when
the CD4þ cells fall to less than 100e50/ml and Th17 cells are
lost or functionally damaged [24,25]. However, no invasion of
internal organs occurs in these subjects, unless other predis-
posing factors are present, among which numerical or func-
tional impairment of innate immunity cells, particularly the
neutrophils are of prime importance [19,26].
Despite the relevant information above, it is unclear how
and where Candida cells gain access to the systemic
compartment from an intact or damaged epithelialcompartment, and which determinants of hostefungus inter-
action play a critical role in dissemination to internal organs
from mucosal disease.
In an attempt to gain some insight into this very relevant
aspect of candidiasis, we used a previously described experi-
mental model of oropharyngeal candidiasis [12] to examine the
course of infection in corticosteroid-treated Il17a/ and WT
mice. This model uses a real-time monitoring of the spatial and
temporal progression of infection, coupled with standard CFU
enumeration. By this approach, here we demonstrate that
steroid-treated Il17a/ mice develop systemic infection from
Fig. 6. Neutrophils activity. Oxidative burst of peritoneal neutrophils (4  106/ml) from Il17a/ and WT mice, incubated in the presence or absence of rIL-17A
(100 ng/ml), was evaluated after 6 days of infection in the presence or absence (Medium) of PMA (100 ng/ml) or C. albicans gLUC59 (2  106/ml). Data are from
one of five experiments with similar results (A). At day 0 and þ6 post-infection, the percentages of killing activity from saliva (B) and phagocytic and killing
capacity (C) of peritoneal neutrophils incubated in the presence or absence of rIL-17A (100 ng/ml), were determined after 1 and 2 h of incubation with C. albicans
gLUC59 respectively. *p < 0.05 was considered significant.
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do not bring about systemic candidiasis from local infection.
The presence of IL-17B was detected in Il17a/ mice and the
production of this cytokine was similar to that observed in WT
mice suggesting that not IL-17B compensatory expression was
present in I17a/mice. Moreover, it has been reported that IL-
17A deficiency does not affect the production of other family
members [16], suggesting that also IL17F is normally produced.
Contrary to what observed by Bishu S. et al. [27] steroid treat-
ment alone, which to some extent favors by itself a late estab-
lishment of low-grade OPC, does not bring about systemic
candidiasis from local infection in normal mice. On the other
hand, in our experimental system Il17a/mice without steroid
treatment did not develop systemic candidiasis from local
infection. Thus, the apparent loss of intestinal epithelial barrier
caused by IL-17A absence is per se insufficient for C. albicans
stably infecting the internal organs, suggesting that the presence
of another predisposing factor to systemic infection is essential.
This model therefore closely mimics the situation of HIV-
infected subjects where loss of Th17 cells in advanced stages
of mucosal infection does not lead to systemic Candida spread
in the absence of a predisposing factor or treatment, particularly
those affecting number and/or function of neutrophils.
Development of systemic infection in Il17a/ mice most
likely occurs via the small intestine, particularly duodenal and
ileum tracts. In the intestine of Il17a/ mice the mucosal
layer was almost completely destroyed and this could be a
critical event considering that this layer is particularly
important as defensive wall of the intestinal epithelia, also by
preventing the adhesion of C. albicans to the epithelial sur-
face. It is of interest that in the non-intestinal tracts, particu-
larly the esophageal one, severe mucosal damage was
nonetheless accompanied by remarkable inflammatory in-
filtrates in the shape of an apparent physical barrier to fungal
translocation. This suggests that though grossly damaged, the
above tracts were probably less pervious to translocation of
fungal cells which might have been substantially retained in
these tissues. Immunosuppression with steroids will likely
promote infection with resident gut bacteria, therefore we
cannot completely exclude that resident bacteria may be
involved in the gut damage, however a separate study is
necessary to unravel this issue. Previous investigations from
Gaffen's research group showed that Th17 and IL-17A are
critical for host defense against oral candidiasis. This was
related to the inhibition of neutrophils recruitment, reduced
expression of b-defensins as well as reduced candidacidal
activity of saliva [8]. However, Gaffen's research group
detected a large neutrophilic infiltrate in resistant mice after C.
albicans inoculation, which was greatly diminished in sus-
ceptible (IL-17RAKO) mice [8]. Actually, we noticed an equal
level of neutrophils infiltrate in both groups of animals. This
apparent discrepancy could be due to different strain of mice
used. In particular Gaffen et al. used IL-17RAKO, while in our
experimental system Il17a/ mice were used. Indeed, we also
observed that IL-17B was produced at similar levels in both
WT and Il17a/ mice and the presence of this cytokine could
account for neutrophils infiltration. Although antimicrobialpeptides produced by non-hematopoietic cells at the site of
infection may be involved in the observed candidacidal ac-
tivity, it is likely that in our experimental setting the killing
activity observed at the site of infection is also mediated by
antimicrobial peptides from recruited neutrophils.
Indeed, genes induced by IL-17 encode antimicrobial pro-
teins such as neutrophils-activating factor [28] and there is a
general consensus about the protective role of IL-17A and IL-
17A receptor (IL-17RA) in disseminated candidiasis [6,29].
Other recent papers have described different mouse models of
gastrointestinal candidiasis [30]. Indeed, intragastric inocula-
tion successfully leads to colonization of the gastrointestinal
tract under various conditions such as immunosuppression
[31], malnutrition [32] or infant mouse model [33]. In these
models it has been shown that a gastrointestinal colonization
could be a source of hematogenous candidiasis. A recent
interesting paper by Hise et al. [34] showed that Dectin-1,
NLRP3 and TLR2 are essential for preventing dissemination
from a mucosal source. Here we demonstrate for the first time
that IL-17A is critical for preventing systemic dissemination
from oropharyngeal candidiasis and that the absence of IL-
17A is correlated with severe damage of the gut, loss of
fungal retention barrier and access of the fungus to the liver
giving rise to classic abscesses of hepatic candidiasis. It has
been recently demonstrated that Dectin-1 and NLRP3, that are
involved in IL-1b production [35], are essential for preventing
Candida dissemination from a mucosal source [34]. Our data
argue that IL-17A should be added to Dectin-1 and NLRP3 as
functionally involved in contrasting the spread of the fungus to
the systemic compartment, even in the presence of an immu-
nosuppressant such as the corticosteroid. However, our histo-
logical analysis also demonstrate that in the organs of Il17a/
mice, particularly in the esophagus, there is a massive infil-
tration of inflammatory cells including neutrophils. This in-
dicates that, despite the absence of IL-17A, which is known to
be chemotactic for neutrophils, Il17a/ mice are still able to
recruit neutrophils in infected organs, and, in some instances
(see above) the infiltrating cells assume the apparent shape of
a sort of fungus-retaining barrier. Possible replacement of IL-
17A functions by other members of IL-17 family and the
overproduction of other chemotactic cytokines, such as IL-1b,
in Il17a/ mice, could explain the observed recruitment of
the neutrophils. Of importance, the neutrophils from Il17a/
mice appear to be partially impaired in their anticandidal ac-
tivity compared to the neutrophils from WT infected mice.
Hence, the presence of neutrophils does not completely mirror
their efficacy in terms of antifungal activity. This could
explain why in Il17a/ mice fungal cells escape from the
local compartment to disseminate elsewhere. Moreover, the
neutrophils population was overrun by infiltrating fungus to
the point where they can no longer cope with the numbers of
encountered fungal cells. While this is consistent with the
described influence of IL-17A on the expression of antimi-
crobial proteins such as b-defensins by innate immune cells
[8,36], it is unclear whether the here reported partial impair-
ment of antifungal activity is per se responsible of C. albicans
passage from mucosal to systemic infection. These aspects, as
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cytokines possibly over-expressed in Il17a/ mice deserve
further investigations in our model. Conti et al. reported that
no evidence of kidney infection was observed in IL-17RAKO
mice with oral candidiasis [8]. This apparent discrepancy
could be due to different mice used, different inoculum of
yeast and different time of CFU determination. In particular
Conti et al. used IL-17RA-deficient mice, while we used
Il17a/ mice. In addition we used a lower dose of C. albicans
(1 log less), this allowed to late determination of C. albicans
load in the kidneys that was specifically performed at day 6
and 8 post-infection. This relatively low dose of infection
therefore could closely mimic the human infection.
In humans, hematogenous candidiasis is clinically a typical
example of an endogenous infection because of C. albicans
colonizes the alimentary tract and the translocation occurs
particularly in immunocompromised patients due to intestinal
barrier damage caused by chemotherapy for cancer or infections
[37]. Moreover, it seems that there is an anatomical comparti-
mentalization of candidiasis related to various diseases [38,39].
It has been recently underlined that liver lesions, in high
risk patients, after one episode of candidemia within the first 2
weeks, define hepatosplenic candidiasis [39,40]. Indeed, pa-
tients with hematologic malignancies in stages of recovery
from granulocitopenia have been reported with increasing
frequency to suffer from invasive candidiasis localized into the
liver [41e43]. Here we report for the first time that the hepatic
candidiasis can be secondary to a high-grade OPC. This
observation, could be of clinical interest and help timely
diagnosis when OPC is associated with liver lesions in patients
with hematological malignancies in which some invasive
diagnostic procedures are precluded by thrombocytopenia.
In conclusion, our results describe a mouse model that, from
oropharyngeal candidiasis, brings to disseminated candidiasis.
More importantly, our data point out that the presence of IL-17A
is critical for preventing invasive infection, particularly hepatic
dissemination. Importantly, the shift to disseminated infection
from OPC does not appear to be due to lack of phagocytosis-
competent neutrophils recruitment to infected mucosa in
Il17a/ mice but rather be favored by some impairment of
neutrophils anti-Candida functions. This model could be
particularly exploited to unravel the biological mechanisms
allowing C. albicans and possibly other human commensal
microorganisms to translocate from intestine to internal organs,
hence causing invasive, potentially lethal infections.
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